Entity Public Float of Akari Therapeutics Plc from 30 Jun 2014 to 30 Jun 2024

Taxonomy & unit
dei: USD
Description
The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.
Summary
Akari Therapeutics Plc quarterly Entity Public Float in USD history and change rate from 30 Jun 2014 to 30 Jun 2024.
  • Akari Therapeutics Plc Entity Public Float for the quarter ending 30 Jun 2024 was $14,000,000, a 2.9% increase year-over-year.
Source SEC data
View on sec.gov
Entity Public Float, Quarterly (USD)
Entity Public Float, YoY Quarterly Change (%)

Akari Therapeutics Plc Quarterly Entity Public Float (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q2 2024 $14,000,000 +$400,000 +2.9% 30 Jun 2024 10-K 15 Apr 2025 2024 FY
Q2 2023 $13,600,000 30 Jun 2023 10-K 29 Mar 2024 2023 FY
Q2 2015 $31,193,000 -$3,301,495 -9.6% 30 Jun 2015 10-K 23 Mar 2016 2015 FY
Q2 2014 $34,494,495 30 Jun 2014 10-K 11 Feb 2015 2014 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.